VERA THERAPEUTICS INC. - CLASS A COMMON STOCK

Vera Therapeutics to Participate in the 2022 Jefferies Healthcare Conference

02 Jun 2022 07:30:00 By Nasdaq GlobeNewswire

Vera Therapeutics Announces New Atacicept Phase 2 Clinical Data in Two Oral Presentations at the 59th European Renal Association Congress

20 May 2022 16:05:00 By Nasdaq GlobeNewswire

Vera Therapeutics Provides Business Update and Reports First Quarter 2022 Financial Results

16 May 2022 07:30:00 By Nasdaq GlobeNewswire

Vera Therapeutics to Present at Upcoming Conferences in May 2022

05 May 2022 16:05:01 By Nasdaq GlobeNewswire

Vera Therapeutics Announces Two Oral Presentations at the 59th European Renal Association – European Dialysis and Transplant Association Congress Featuring New Clinical Data on Atacicept in IgA Nephropathy and in Systemic Lupus Erythematosus

03 May 2022 16:33:34 By Nasdaq GlobeNewswire

Vera Therapeutics Selected to Present Interim Phase 2 Data for MAU868 to Treat BK Virus in Kidney Transplant Patients as Oral Late-Breaker at the American Transplant Congress 2022

02 May 2022 19:06:09 By Nasdaq GlobeNewswire

Vera Therapeutics Announces Appointment of Michael M. Morrissey, Ph.D., as Chairman of its Board of Directors

12 Apr 2022 07:30:00 By Nasdaq GlobeNewswire

Vera Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

24 Mar 2022 06:30:00 By Nasdaq GlobeNewswire

Vera Therapeutics to Host BK Virus Webinar Featuring Stanley C. Jordan, M.D., World-Renowned Transplant Nephrologist and Pioneering Kidney Transplant Researcher

21 Mar 2022 07:30:00 By Nasdaq GlobeNewswire

Vera Therapeutics to Host Business Update Call

17 Mar 2022 07:30:00 By Nasdaq GlobeNewswire

Vera Therapeutics to Participate in the 42nd Annual Cowen Health Care Conference

01 Mar 2022 07:30:00 By Nasdaq GlobeNewswire

Vera Therapeutics Announces Closing of Upsized Public Offering of Class A Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

14 Feb 2022 16:01:00 By Nasdaq GlobeNewswire

Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock

10 Feb 2022 08:46:50 By Nasdaq GlobeNewswire

Vera Therapeutics Announces Commencement of Public Offering of Class A Common Stock

07 Feb 2022 17:24:50 By Nasdaq GlobeNewswire

Vera Therapeutics Announces Phase 3 Clinical Trial for Atacicept in Lupus Nephritis

18 Jan 2022 07:30:00 By Nasdaq GlobeNewswire

Vera Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

04 Jan 2022 07:30:01 By Nasdaq GlobeNewswire

Vera Therapeutics Announces Acquisition of Monoclonal Antibody From Pfizer to Treat BK Virus in Transplant Patients

17 Dec 2021 07:30:00 By Nasdaq GlobeNewswire

Vera Therapeutics Announces Appointment of Kimball Hall to Board of Directors

14 Dec 2021 07:30:00 By Nasdaq GlobeNewswire

Vera Therapeutics to Present at Upcoming Investment Conferences in November 2021

10 Nov 2021 16:15:01 By Nasdaq GlobeNewswire

Vera Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update

10 Nov 2021 07:15:00 By Nasdaq GlobeNewswire